Healthcare Moves: A Monthly Summary of Hires and Layoffs

30 Nov 2023
medcitynews.com
Executive ChangeAcquisition
This roundup will be published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive appointment, resignation or layoff that you would like to share for this roundup or the MedCity Moves podcast, please reach out to moves@medcitynews.com. Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry. Hires Beth Israel Lahey Health named Yael Heher as its first chief quality officer. She most recently served as vice chair of pathology, quality and safety at Massachusetts General Hospital. Centene welcomed Susan Smith as its new COO. Before Centene, Smith spent nearly 20 years at Humana, serving most recently as its president of clinical, quality and enterprise solutions. Virtual mental health provider Charlie Health appointed two new senior leaders — Udi Milo as chief product officer and Don Johnson as head of digital innovation. In the past, Milo has held product leadership positions at Tinder, Lyft, Pinterest and LinkedIn. As for Johnson, he spent 23 years at UnitedHealth Group. Redox, a company that connects EHRs to healthcare products and services, welcomed Trip Hofer as its new CEO. In the past, Hofer has held executive positions at Optum and CVS Health, as well as served as CEO of AbleTo, which provides behavioral telehealth services. In November, he was also appointed to the title of partner at .406 Ventures, a Boston-based venture capital firm focused on healthcare tech. Digital health company Sharecare announced that Brent Layton will become its new CEO in January. Before Sharecare, Layton had a lengthy career at Centene, serving recently as its COO. AHIP chose Pat Geraghty to chair its board of directors in 2024. He is the president and CEO of Florida Blue and its parent company GuideWell. Geraghty will succeed the current chair, Highmark Health CEO David Holmberg, as his two-year term will come to a close at the end of this year. Promotions Houston Methodist tapped Shawn Tittle as its first-ever system chief quality officer. He currently serves as chief medical officer and chief quality officer at one of Houston Methodist’s hospitals. Tittle will step into the new role in January. Mount Sinai Health System announced that Brendan Carr, its chair of emergency medicine, will become the health system’s new CEO in early 2024. He will replace Kenneth Davis, who’s held the CEO role since 2003. Northwestern Medicine welcomed Jeff Good to its newly created role of chief sustainability executive. He recently served as president of one of the health system’s hospitals. Ochsner Health appointed Yvens Laborde as its first-ever chief community medical officer. In this role, he will lead the system’s strategy to promote healthier and more equitable outcomes across the local community. Labord previously served as Ocshner’s medical director of global health education and public health. Layoffs Medical device maker Acutus Medical announced that it will lay off 65% of its workforce as part of a major restructuring, which means about 150 workers will lose their jobs. Moving forward, the company said its main focus will be manufacturing left-heart access products for Medtronic. EHR vendor NextGen Healthcare said it is laying off 65 employees in Pennsylvania, 84 employees in St. Louis and 99 employees in Maryland due to the company recently being purchased by a private equity firm. Thermo Fisher Scientific announced plans to close its plant in Auburn, Alabama. The biotech company said it will lay off nearly 100 workers. Walgreens said that it will lay off about 5% of its corporate workforce, which is 267 employees. This round of layoffs came after the company laid off about 10% of its corporate workforce in May.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.